$0.6725
0.046.75%
Pre-Market: 5:59 PM EDT
Comments
Loading...
MiNK Therapeutics (NASDAQ:INKT) Stock, Earnings Estimates, EPS, And Revenue
MiNK Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 20
EPS Estimate
$-0.080
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of MiNK Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
MiNK Therapeutics (INKT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-14 | $-0.05 | $-0.08 | 37.5 % |
| Jun 2024 | 2024-08-13 | $-0.07 | $-0.10 | 30.0 % |
| Mar 2024 | 2024-05-14 | $-0.11 | $-0.15 | 26.7 % |
| Dec 2023 | 2024-03-21 | $-0.16 | $-0.15 | -6.67 % |
MiNK Therapeutics (INKT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is MiNK Therapeutics (NASDAQ:INKT) reporting earnings?
MiNK Therapeutics (INKT) is scheduled to report earnings on March 20, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for MiNK Therapeutics (NASDAQ:INKT)?
The Actual EPS was $-0.05, which beat the estimate of $-0.08.
What were MiNK Therapeutics’s (NASDAQ:INKT) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.